First-Line Administration of Fibrinogen Concentrate in the Bleeding Trauma Patient: Searching for Effective Dosages and Optimal Post-Treatment Levels Limiting Massive Transfusion—Further Results of the RETIC Study
Innerhofer, N.; Treichl, B.; Rugg, C.; Fries, D.; Mittermayr, M.; Hell, T.; Oswald, E.; Innerhofer, P.; on behalf of the RETIC Study Group. First-Line Administration of Fibrinogen Concentrate in the Bleeding Trauma Patient: Searching for Effective Dosages and Optimal Post-Treatment Levels Limiting Massive Transfusion—Further Results of the RETIC Study. J. Clin. Med. 2021, 10, 3930. https://doi.org/10.3390/jcm10173930
Innerhofer N, Treichl B, Rugg C, Fries D, Mittermayr M, Hell T, Oswald E, Innerhofer P, on behalf of the RETIC Study Group. First-Line Administration of Fibrinogen Concentrate in the Bleeding Trauma Patient: Searching for Effective Dosages and Optimal Post-Treatment Levels Limiting Massive Transfusion—Further Results of the RETIC Study. Journal of Clinical Medicine. 2021; 10(17):3930. https://doi.org/10.3390/jcm10173930
Chicago/Turabian StyleInnerhofer, Nicole, Benjamin Treichl, Christopher Rugg, Dietmar Fries, Markus Mittermayr, Tobias Hell, Elgar Oswald, Petra Innerhofer, and on behalf of the RETIC Study Group. 2021. "First-Line Administration of Fibrinogen Concentrate in the Bleeding Trauma Patient: Searching for Effective Dosages and Optimal Post-Treatment Levels Limiting Massive Transfusion—Further Results of the RETIC Study" Journal of Clinical Medicine 10, no. 17: 3930. https://doi.org/10.3390/jcm10173930